Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Retatrutide is being developed by Eli Lilly and Company , which has indicated plans to submit regulatory applications following the completion of Phase 3 trials
During your initial consultation with Harpenden Medical, we will work with you to devise a suitable treatment plan while giving you all the information and guidance you need
Net Quantity:10mg per vial
Nourishes with a rich, creamy formula, leaving skin softer
The choice depends on the patient's absorption capacity, condition severity, and ability to comply with the treatment regimen
US$ 28.21
US$ 29.39
US$ 26.48
US$ 23.28
US$ 28.78
US$ 20.07
